Long-axis gray-scale ultrasound image shows hypoechoic lesion. Lesion was...
Long-axis gray-scale ultrasound image shows hypoechoic lesion. Lesion was classified by study radiologist as BI-RADS category 4A.

Image credit: ARRS/AJR

News • Deep learning CAD in sonography

Computer-aided diagnosis improves breast ultrasound expertise

According to an accepted manuscript, deep learning–based computer-aided diagnosis (CAD) for breast lesion classification on ultrasound significantly improved radiologists' diagnostic performance—particularly for reducing the frequency of benign breast biopsies.

The findings were published in the American Journal of Roentgenology (AJR)

Compared with the literature supporting CAD at tertiary and/or urban centers, results from this prospective multicenter study of radiologists without breast ultrasound expertise "support CAD in settings with incomplete access to breast imaging expertise," wrote corresponding author Li-Gang Cui, MD, from Peking University Third Hospital in Beijing, China. 

The study included patients scheduled to undergo biopsy or surgical resection of a breast lesion, classified as BI-RADS category 3-5 on prior breast ultrasound, at eight Chinese secondary or rural hospitals from November 2021 to September 2022. Patients underwent an additional investigational breast ultrasound, both performed and interpreted by a radiologist with no expertise in the modality. Hybrid body-breast imagers—radiologists lacking breast subspecialty training or in whom breast ultrasound accounted for less than 10% of their ultrasounds performed annually—then assigned a BI-RADS category. CAD results were used to upgrade reader-assigned BI-RADS category 3 lesions to category 4A, as well as for downgrading BI-RADS 4A lesions to 3. Histologic results of biopsy or resection served as the researchers' reference standard. 

Long-axis greyscale ultrasound image shows results of CAD analysis. CAD...
Long-axis greyscale ultrasound image shows results of CAD analysis. CAD provided result of “possibly benign” for both images. Lesion was therefore downgraded to category 3 based on CAD output. Pathologic assessment based on surgical resection was fibroadenoma.

Image credit: ARRS/AJR

Ultimately, application of CAD to interpretations by radiologists without breast ultrasound expertise resulted in upgrade of 6.0% (6/100) of BI-RADS category 3 assessments to category 4A, of which 16.7% (1/6) were malignant, and downgrade of 79.1% (87/110) of category 4A assessments to category 3, of which 4.6% (4/87) were malignant. 

Because institutions lacking breast imaging expertise may also suffer from capacity issues to perform image-guided breast biopsies and pathologic evaluation of biopsy specimens, decreasing benign biopsies care of CAD "would be impactful," the authors of this manuscript added. 

Source: American Roentgen Ray Society


Read all latest stories

Related articles


News • AI milestone

ChatGPT-4 passes radiology board exam

The latest version of ChatGPT passed a radiology board-style exam, highlighting the potential of large language models but also revealing limitations that hinder reliability, new research shows.


News • Using portable ultrasound imaging

AI helpful in triaging breast masses in low-resource areas

AI can analyze breast mass images from low-cost portable ultrasound machines and accurately identify cancer, according to a new study. This could prove useful for triage in low-resource settings.


News • DBT vs. standard digital mammography

Huge study shows: Tomosynthesis better at breast cancer detection

In a study of over a million women, digital breast tomosynthesis (DBT) showed improved breast cancer screening outcomes over screening with standard digital mammography alone.

Related products

3DQuorum SmartSlices

Artificial Intelligence

Hologic · 3DQuorum SmartSlices

Hologic, Inc.
Genius AI Detection*

Artificial Intelligence

Hologic · Genius AI Detection*

Hologic, Inc.

Artificial Intelligence

Fujifilm · REiLI

teamplay Mammo Dashboard

Business Intelligence

Siemens Healthineers · teamplay Mammo Dashboard

Siemens Healthcare GmbH

Artificial Intelligence

ScreenPoint Medical · Transpara

ScreenPoint Medical
Subscribe to Newsletter